When Daria Mochly-Rosen discovered a compound in her lab that promised to lessen the effects of heart attacks, she set out to convince pharmaceutical companies to develop it.
She couldn’t.
So the professor of chemistry and systems biology at Stanford University’s School of Medicine took a leave of absence and started her own company to further test and potentially commercialize the drug.
